PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-12-18 (2)

Date Title Company
18-Dec-2025 Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) Businesswire